BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10440069)

  • 1. Complement haemolytic activity, circulating immune complexes and the morbidity of sickle cell anaemia.
    Anyaegbu CC; Okpala IE; Aken'ova AY; Salimonu LS
    APMIS; 1999 Jul; 107(7):699-702. PubMed ID: 10440069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement Levels in Nigeria Patients with Sickle Cell Anaemia in the Asymptomatic State.
    Okeke TI; P Musa BO; Babadoko AA; Jamoh BY
    Niger J Clin Pract; 2018 Sep; 21(9):1139-1143. PubMed ID: 30156198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C4, BF, C3 allele distribution and complement activity in healthy aged people and centenarians.
    Bellavia D; Fradà G; Di Franco P; Feo S; Franceschi C; Sansoni P; Brai M
    J Gerontol A Biol Sci Med Sci; 1999 Apr; 54(4):B150-3. PubMed ID: 10219002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunological aspects of sickle cell syndrome with particular reference to circulating immune complexes.
    Kazeem AA
    East Afr Med J; 1990 Nov; 67(11):761-9. PubMed ID: 2076676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of serum alpha-fetoprotein to circulating immune complexes and complements in patients with hepatitis B surface antigen-positive hepatocellular carcinoma.
    Tsai JF; Tsai JH; Chang WY
    Gastroenterol Jpn; 1990 Jun; 25(3):388-93. PubMed ID: 1694150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune complexes in retinitis pigmentosa.
    Heredia CD; Huguet J; Cols N; Engel P; García-Calderón PA
    Br J Ophthalmol; 1984 Nov; 68(11):811-4. PubMed ID: 6333894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation in asymptomatic patients with sickle cell anaemia.
    Wilson WA; Thomas EJ; Sissons JG
    Clin Exp Immunol; 1979 Apr; 36(1):130-9. PubMed ID: 466858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes in retinitis pigmentosa.
    García-Calderón PA; Engel P; Cols N; Heredia García CD
    Ophthalmic Paediatr Genet; 1984 Dec; 4(3):199-202. PubMed ID: 6545398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
    Wouters D; Brouwer MC; Daha MR; Hack CE
    Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circulating immune complexes and complement breakdown products in childhood IgA nephropathy].
    Tanaka C; Suhara Y; Kikkawa Y
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):709-17. PubMed ID: 1770631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of alternative pathway and factor B haemolytic activities in patients with systemic lupus erythematosus: correlations with the alternative pathway regulatory proteins.
    Aguado MT; Perrin LH; Ramirez R; Miescher PA; Lambert PH
    Clin Exp Immunol; 1980 Dec; 42(3):495-505. PubMed ID: 6163579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating immune complexes in sickle cell anaemia.
    Villaescusa R; Santos MN; Espinosa E; Hernández P
    Haematologia (Budap); 1986; 19(3):185-91. PubMed ID: 3781352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
    Kievits F; Kijlstra A
    Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
    Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
    Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of circulating C1q-binding activity in chronic liver disease: a study of 133 cases.
    Bigi G; Monarca A; Adelasco L; Natangelo R; Croce G; Bastia A; Fiorini G
    Ric Clin Lab; 1984; 14(4):629-33. PubMed ID: 6335289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma L-Arginine in Sickle Cell Anaemia Patients in Crises and its Correlation with Markers of Severity of Disease.
    Aworanti OW; Akingbola TS; Adeomi A; Alagbe AE; Salako AO
    West Afr J Med; 2021 Apr; 38(4):366-373. PubMed ID: 33902958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complement and serum immunoglobulins in homozygous and heterozygous sickle cell anemia in Senegal].
    Dieye TN; Ndiaye O; Ndiaye AB; Thiam D; Fall-Seck K; Diop S; Diop BM; Fall M; Diakhaté L
    Dakar Med; 1999; 44(2):175-9. PubMed ID: 11957280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement components C3, C4, and Bf in six nonhuman primate species.
    McMahan MR
    Lab Anim Sci; 1982 Feb; 32(1):57-9. PubMed ID: 6804713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the alternative pathway of human complement by haemoglobin.
    Wilson WA; Thomas EJ
    Clin Exp Immunol; 1979 Apr; 36(1):140-4. PubMed ID: 111881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activation of the alternative complement pathway in pleural fluid of patients with pneumonia].
    Aguado MT; Celada A
    Allergol Immunopathol (Madr); 1982; 10(3):215-20. PubMed ID: 6924537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.